Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Damora Therapeutics Inc
NASDAQ:DMRA
Damora Therapeutics Inc
NASDAQ:DMRA
Price:
20.24
USD
3.53%
Market Closed
Market Cap:
$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Damora Therapeutics Inc
NASDAQ:DMRA
|
US |
|
D
|
Descon Oxychem Ltd
KAR:DOL
|
PK |
|
Nisshin OilliO Group Ltd
OTC:NSOMF
|
JP |
|
P
|
PCC Exol SA
WSE:PCX
|
PL |
|
OKP Holdings Ltd
SGX:5CF
|
SG |
|
PCC Exol SA
F:9B2
|
PL |
Wall St Price Targets
DMRA Price Forecast
Based on 11 analysts
Based on 11 analysts
+127% Upside
from
$20.24
today
Damora Therapeutics Inc (DMRA)’s 12-month stock price forecast through October 2027 has a consensus target of $45.9, implying 127% upside. The forecast is based on price targets from 11 Wall Street analysts.
DMRA Analyst Rating
No ratings yet
No ratings yet
Damora Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMRA's stock price target?
Price Target
45.9
USD
45.9
USD
According to Wall Street analysts, the average 1-year price target for DMRA is 45.9 USD with a low forecast of 40.4 USD and a high forecast of 63 USD.